Vaccine and Treatment Evaluation Units (VTEU) 24-0003
$86,820UM1FY2025AINIH
Baylor College Of Medicine, Houston TX
Investigators
Linked publications & trials
Paper 39774938Paper 39158584Paper 39040211Paper 38518789Paper 38408357Paper 38332733Paper 37561027Paper 37451878Paper 37440227Paper 37433788Paper 37383244Paper 37330602Paper 36895286Paper 36442063Paper 35898343Paper 35818363Paper 35798000Paper 35785530Paper 35734087Paper 35675078Paper 35544369Paper 35535503Paper 35145311Paper 35081298Paper 35081293Paper 34931200Paper 34910859Paper 34812653Paper 34672949Paper 34671773Paper 34409989Paper 34379740Paper 34278310Paper 33306283Paper 32445440
Abstract
BAYLOR COLLEGE OF MEDICINE- ABSTRACT The purpose of this Phase 4 study is to compare strategies for prevention of RSV lower respiratory tract disease infection in infants in a single study. Both maternal vaccination with RSVpreF and passive immunization of infant with monoclonal antibody at birth are recommended. Sequential administration of both products for some infants may be indicated but this has not been studied. This study will evaluate the safety and immunogenicity of 4 prevention strategies using these approved products. It is expected that the results of this study will policy recommendations and clinical decision-making for pregnant women and their infants.
View original record on NIH RePORTER →